Organigram Global (OGI) Tax Provisions (2018 - 2025)

Organigram Global (OGI) posted quarterly Tax Provisions of -$73873.1 for Q1 2025, up 99.53% on a QoQ basis from -$15.6 million in Q3 2020.

Organigram Global (OGI) Tax Provisions (2018 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Tax Provisions for 4 consecutive years, with -$73873.1 the latest figure, recorded in Q1 2025.

Quarterly Tax Provisions changed N/A year-over-year to -$73873.1 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$23.5 million (changed N/A YoY) and the FY2025 annual result came in at -$9.9 million, changed N/A from the prior year.
Tax Provisions advanced to -$73873.1 in Q1 2025 per OGI's latest filing, from -$15.6 million in the prior quarter.
Over the last five years, Tax Provisions for OGI reached as high as -$73873.1 in Q1 2025 and fell as low as -$73873.1 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	67.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	157.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	676.90 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	43.40 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-423.70 Mn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	48.90 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	30.00 Mn
10	Organigram Global	89.89 Mn	122.96 Mn	28.97 Mn	-

Download Data